Midostaurin, a Novel Protein Kinase Inhibitor for the Treatment of Acute Myelogenous Leukemia: Insights from Human Absorption, Metabolism, and Excretion Studies of a BDDCS II Drug.
第一作者:
Handan,He
第一单位:
Department of Drug Metabolism and Pharmacokinetics, Novartis Institutes for Biomedical Research, East Hanover, New Jersey handan.he@novartis.com.
作者:
主题词
成年人(Adult);动物(Animals);狗(Dogs);女(雌)性(Female);人类(Humans);白血病, 髓样, 急性(Leukemia, Myeloid, Acute);男(雄)性(Male);质谱分析法(Mass Spectrometry);中年人(Middle Aged);蛋白激酶抑制剂(Protein Kinase Inhibitors);大鼠(Rats);星状孢子素(Staurosporine);青年人(Young Adult)
DOI
10.1124/dmd.116.072744
PMID
28270565
发布时间
2025-02-12
- 浏览2
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文